Indirect standardization

3,873views

Indirect standardization

Year 1

Year 1

Skin histology
Introduction to pharmacology
Skin anatomy and physiology
Wound healing
Introduction to biostatistics
Types of data
Vaccinations
Inflammation
Nuclear structure
Pharmacodynamics: Agonist, partial agonist and antagonist
DNA structure
Anemia: Clinical
Anatomy of the heart
Hypertension
Hypertension: Clinical
Myocardial infarction
Clinical trials
Mitosis and meiosis
Calcium channel blockers
Class III antiarrhythmics: Potassium channel blockers
Pharmacokinetics: Drug elimination and clearance
Pharmacokinetics: Drug metabolism
Pharmacokinetics: Drug absorption and distribution
Acetaminophen (Paracetamol)
Non-steroidal anti-inflammatory drugs
Opioid agonists, mixed agonist-antagonists and partial agonists
Cardiac muscle histology
Blood histology
Artery and vein histology
Arteriole, venule and capillary histology
Loop diuretics
Thiazide and thiazide-like diuretics
Potassium sparing diuretics
Osmotic diuretics
Carbonic anhydrase inhibitors
Bone histology
Cartilage histology
Skeletal muscle histology
Central nervous system histology
Peripheral nervous system histology
Diabetes mellitus
Phenylketonuria (NORD)
Homocystinuria
Familial hypercholesterolemia
Fats and lipids
Cholesterol metabolism
Carbohydrates and sugars
Proteins
Extracellular matrix
Cytoskeleton and intracellular motility
Cell signaling pathways
Citric acid cycle
Electron transport chain and oxidative phosphorylation
Amino acid metabolism
Nitrogen and urea cycle
Nucleotide metabolism
Introduction to biostatistics
Types of data
Probability
Mean, median, and mode
Range, variance, and standard deviation
Standard error of the mean (Central limit theorem)
Normal distribution and z-scores
Type I and type II errors
Study designs
Ecologic study
Cross sectional study
Case-control study
Cohort study
Randomized control trial
Sensitivity and specificity
Positive and negative predictive value
Test precision and accuracy
Atrophy, aplasia, and hypoplasia
Hyperplasia and hypertrophy
Metaplasia and dysplasia
Bone tumors
Osteomyelitis
Osteoporosis
Osteomalacia and rickets
Septic arthritis
Cauda equina syndrome
The Oral Microbiota and Systemic Health
Bacterial structure and functions
Nasal cavity and larynx histology
Trachea and bronchi histology
Bronchioles and alveoli histology
Inheritance patterns
Mendelian genetics and punnett squares
Hardy-Weinberg equilibrium
DNA mutations
Neuromuscular junction and motor unit
Pharmacodynamics: Drug-receptor interactions
Cholinergic receptors
Adrenergic receptors
Blood products and transfusion: Clinical
Muscle contraction
Sliding filament model of muscle contraction
Nervous system anatomy and physiology
Parasympathetic nervous system
Slow twitch and fast twitch muscle fibers
Enteric nervous system
Sympathetic nervous system
Resting membrane potential
Neuron action potential
Cell membrane
Selective permeability of the cell membrane
Blood groups and transfusions
Blood components
Oxygen binding capacity and oxygen content
Oxygen-hemoglobin dissociation curve
Body fluid compartments
Movement of water between body compartments
Platelet plug formation (primary hemostasis)
Coagulation (secondary hemostasis)
Clot retraction and fibrinolysis
Carbon dioxide transport in blood
Bones of the vertebral column
Bones of the vertebral column
Joints of the vertebral column
Joints of the vertebral column
Joints of the wrist and hand
Bones of the upper limb
Fascia, vessels and nerves of the upper limb
Anatomy of the brachial plexus
Anatomy of the arm
Muscles of the forearm
Vessels and nerves of the forearm
Muscles of the hand
Anatomy of the sternoclavicular and acromioclavicular joints
Anatomy of the glenohumeral joint
Anatomy of the elbow joint
Anatomy of the radioulnar joints
Paired t-test
Two-sample t-test
Hypothesis testing: One-tailed and two-tailed tests
Methods of regression analysis
Spearman's rank correlation coefficient
Mann-Whitney U test
Chi-squared test
Kaplan-Meier survival analysis
Incidence and prevalence
Relative and absolute risk
Odds ratio
Attributable risk (AR)
Direct standardization
Indirect standardization
Disease causality
Selection bias
Information bias
Confounding
Innate immune system
Complement system
T-cell activation
B-cell activation, differentiation, and contraction
Cell-mediated immunity of natural killer and CD8 cells
Antibody classes
Upper respiratory tract infection
Heart failure
Lipid-lowering medications: Statins
Lipid-lowering medications: Fibrates
Miscellaneous lipid-lowering medications
Dyslipidemias: Pathology review
Atherosclerosis and arteriosclerosis: Pathology review
Familial hypercholesterolemia
Deep vein thrombosis and pulmonary embolism: Pathology review
Chronic venous insufficiency
Ischemia
ECG cardiac infarction and ischemia
Angina pectoris
Aneurysms
Asthma: Clinical
Chronic bronchitis
Emphysema
Pulmonary hypertension
Idiopathic pulmonary fibrosis
Bronchiectasis
Lung cancer
Chronic obstructive pulmonary disease (COPD): Clinical
Respiratory distress syndrome: Pathology review
Myocardial infarction
Vasculitis
ACE inhibitors, ARBs and direct renin inhibitors
Adrenergic receptors
Adrenergic antagonists: Alpha blockers
Class II antiarrhythmics: Beta blockers
Adrenergic antagonists: Beta blockers
Antiplatelet medications
Anticoagulants: Heparin
Anticoagulants: Warfarin
Anticoagulants: Direct factor inhibitors
Calcium channel blockers
cGMP mediated smooth muscle vasodilators
Bronchodilators: Beta 2-agonists and muscarinic antagonists
Bronchodilators: Leukotriene antagonists and methylxanthines
Pulmonary corticosteroids and mast cell inhibitors
Arteriole, venule and capillary histology
Microcirculation and Starling forces
Blood pressure, blood flow, and resistance
Resistance to blood flow
Lymphatic system anatomy and physiology
Laminar flow and Reynolds number
Compliance of blood vessels
Pressures in the cardiovascular system
Physiological changes during exercise
Measuring cardiac output (Fick principle)
Stroke volume, ejection fraction, and cardiac output
Frank-Starling relationship
Pressure-volume loops
Changes in pressure-volume loops
Cardiac work
Cardiac preload
Cardiac afterload
Law of Laplace
Baroreceptors
Renin-angiotensin-aldosterone system
Chemoreceptors
Cardiac conduction system
Action potentials in pacemaker cells
Action potentials in myocytes
Cardiac excitation-contraction coupling
Cardiac contractility
ECG basics
Cerebral circulation
Coronary circulation
Respiratory system anatomy and physiology
Reading a chest X-ray
Lung volumes and capacities
Anatomic and physiologic dead space
Alveolar surface tension and surfactant
Ventilation
Regulation of pulmonary blood flow
Zones of pulmonary blood flow
Pulmonary shunts
Ventilation-perfusion ratios and V/Q mismatch
Airflow, pressure, and resistance
Diffusion-limited and perfusion-limited gas exchange
Gas exchange in the lungs, blood and tissues
Oxygen binding capacity and oxygen content
Oxygen-hemoglobin dissociation curve
Carbon dioxide transport in blood
Carpal tunnel syndrome

Transcript

Watch video only

In epidemiology, we often want to compare the mortality rates, or the frequency of deaths, and the morbidity rates, or the frequency of a certain disease, in different populations.

Typically, we do this by calculating the crude mortality rate for each population, which is the number of deaths in that occur within a certain timespan, like a year, divided by the total number of people in the population.

For example, let’s say we want to compare the crude mortality rates in two cities - City 1, which has a population of 23,000 people, and City 2, which has a population of 26,000 people.

In one year, there were 68 deaths in City 1, and 105 deaths in City 2. So the crude mortality rate in City 1 is 68 deaths divided by 23,000 people, or 0.003. This means that there were 3 deaths for every 1,000 people that year in City 1.

The crude mortality rate for City 2 is 105 divided by 26,000, which equals 0.004, or 4 deaths per 1,000 people.

We can use a mortality ratio, or a ratio of two mortality rates, to compare the crude mortality rate of City 1 to the mortality rate of City 2, and we get a ratio of 3 to 4. And if we divide both sides by the bigger number, 4, we get a mortality ratio of 0.75 to 1, which means that, in one year, City 1 had a mortality rate 25% lower than City 2. That may convince some folks to pack their bags and move to City 1!

Sometimes though, calculating the crude mortality ratio doesn’t provide an accurate picture of the two populations, and this is usually because the populations have different distributions of certain characteristics, like age, sex, or race.

For example, let’s say City 1 and City 2 have different age distributions, so City 1 has an older population with a large percentage of people over the age of 40, whereas City 2 has a younger population with only a small percentage of people over the age of 40.

Typically, mortality rates tend to be higher in older populations and lower in younger populations. So, we can speculate that if City 2 has a smaller percentage of older people, then the crude mortality rate for City 2 might be lower. Perhaps it’s time to put down those bags and pick up a calculator instead.

Standardization is a method that’s used to adjust for differences in characteristics between two populations, and when standardization is used to adjust for age, the result is called an age-adjusted rate.

Oftentimes, standardization is used to adjust mortality rates, but it can also be used to adjust incidence rates - the frequency of new diseases - or prevalence rates - the frequency of currently existing diseases.

There are two ways to calculate standardized rates, direct standardization and indirect standardization.

Direct standardization is used when the number of events or the mortality rates in each age group within the population, is known, whereas indirect standardization is used when the number of events or the mortality rates in each age group within the population is not known.

So let’s say we know the age- specific mortality rates in City 1 but we don’t know the age- specific mortality rates in City 2. In that situation, we have to use indirect standardization.

In City 1, let’s say that within the total population of 23, 000 and 68 deaths, there are 18,000 people in the over 40 age group, and 5,000 people in the under 40 age group. And let’s say that we know the age- specific mortality rate is 0.001 in the over 40 age group, and 0.01 in the under 40 age group.

Multiplying 0.001 by 18,000 people gives us 18 deaths in the over 40 group, and multiplying 0.01 by 5,000 gives us 50 deaths in the under 40 group, adding up to the total of 68 total deaths in City 1.

Key Takeaways

In statistics, standardization is a method used to adjust for differences in characteristics (e.g. mortality rates, incidence or prevalence rates, etc.) between two populations. When the number of events or the mortality rates in each age group is unknown, it is indirect standardization. On the other hand, when the number of events or the mortality rates in each age group is known, it is direct standardization.